Congenital heart defects genetic architecture in a small cohort: an integrated approach to prioritizing variants - Report - MDSpire

Congenital heart defects genetic architecture in a small cohort: an integrated approach to prioritizing variants

  • By

  • Anna V. Korobeinikova

  • Ekaterina S. Petriaikina

  • Dmitry I. Tychinin

  • Vladimir S. Yudin

  • Naida I. Bulaeva

  • Sayaly M. Gyulmamedova

  • Georgy A. Khugaev

  • Tatiana V. Sukhacheva

  • Ekaterina A. Snigir

  • Sergey I. Mitrofanov

  • Antonina M. Rumyantseva

  • Dmitry V. Svetlichnyy

  • Sergey M. Yudin

  • Elena Z. Golukhova

  • Veronika I. Skvortsova

  • July 6, 2026

  • 0 min

Share

Clinical Report: Genetic Framework of Congenital Heart Defects in a Small Patient Cohort

Overview

This study investigates the genetic architecture of congenital heart defects (CHD) through whole-genome sequencing in a cohort of 50 patients. It identifies novel genetic variants associated with specific CHD subtypes.

Background

Congenital heart defects are among the most common congenital anomalies, affecting approximately 1% of newborns and leading to significant morbidity and mortality. Understanding the genetic factors contributing to CHD is crucial. Despite advances in genetic research, many cases remain without identified genetic causes.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Whole-genome sequencing identified novel coding and non-coding variants linked to CHD.
  • Specific genetic associations were found for CHD subtypes: JARID2 with PDA, GOSR2/TBX18 with VSD, PCDHA9 with ASD, and a multi-gene signature with atrioventricular septal defects.
  • COL11A2 and PCOLCE2 were identified as potential collagen-related candidates for CHD pathogenesis.
  • The study highlights the limited discriminatory capacity of current genomic annotation databases.

Clinical Implications

The findings suggest that integrating clinical classifications with genomic data may enhance genetic risk assessments for CHD. This approach could lead to better identification of at-risk individuals and inform clinical decision-making.

Conclusion

This research expands the understanding of the genetic factors underlying congenital heart anomalies.

Related Resources & Content

  1. Clinical Research in Cardiology, 2009 -- Genetic Factors Involved in Congenital Atrial Septal Defects
  2. Pediatric Cardiology, 2024 -- Resources for Genetic Testing and Clinical Approaches in Pediatric Cardiomyopathy Programs
  3. Frontiers in Cardiovascular Medicine, 2026 -- Emergency criteria and lifesaving intervention windows for high-risk critical congenital heart disease: a perspectives
  4. ACC/AHA publica nueva guía sobre el manejo de cardiopatías congénitas en adultos | American Heart Association
  5. Genome sequencing is critical for forecasting outcomes following congenital cardiac surgery | Nature Communications
  6. Pediatric Cardiology — Inequities in Prenatal Detection of Critical Congenital Heart Disease Persist, Highlighting Racial/Ethnic and Socioeconomic Gaps Alongside Technical Challenges
  7. ACC/AHA publica nueva guía sobre el manejo de cardiopatías congénitas en adultos | American Heart Association
  8. Genome sequencing is critical for forecasting outcomes following congenital cardiac surgery | Nature Communications
  9. Molecular diagnoses and candidate gene identification in the congenital heart disease cohorts of the 100,000 genomes project - PMC
  10. Yield of Whole Genome Sequencing for Pathogenic Single Nucleotide Variants in Congenital Heart Disease: A Systematic Review and Meta‐Analysis
  11. Genetic findings of children with congenital heart diseases using chromosomal microarray and trio-based whole exome sequencing | Scientific Reports

Original Source(s)

Related Content